BAYN.DE is trading 5.2% up today at $48.41 after a U.S. Supreme Court decision scaled back Roundup cancer lawsuit risk.
- The ruling triggered a sharp reassessment of the company’s long-running litigation overhang, which had previously been a major drag on investor sentiment.
- The stock extended its recent rebound, closing at $48.41 on June 30 following a +5.17% session.
- The move appears to be company-specific rather than market-driven, as broader market futures were mildly weaker overnight.